1784253-05-9
Methanesulfonamide, N-[2-[[5-chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-, hydrochloride (1:1)
2504036-13-7
2504036-13-7
1126602-42-3
852225-20-8
1-[4-(6-nitro-3-pyridinyl)-1-piperazinyl]ethanone
2101739-18-6
RAD51-IN-17
1260364-43-9
2143464-25-7
909089-13-0
SKL2001
1624996-89-9
1456704-49-6
1595278-21-9
GSK717
1620992-67-7
TRANS-4-METHYL-N-[5-[2-(4-METHYLPIPERAZIN-1-YL)-2-OXOETHYL]-4-(2-THIENYL)-1,3-THIAZOL-2-YL]CYCLOHEXANECARBOXAMIDE
6710-48-1
ZEBULARINE
1215333-48-4
R 144053 trihydrochloride
286369-38-8
S 14506 hydrochloride
54642-23-8
JNK INHIBITOR II, NEGATIVE CONTROL
2138882-71-8
KEA1-97
1186195-56-1
827001-82-1
N-[(6-Hydroxy-1-naphthyl)carbamothioyl]-2-furamide
695207-56-8
909089-13-0, CAS No. 909089-13-0,CasNo 909089-13-0,cas 909089-13-0
SKL2001